Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Generex Biotechnology Corp GNBT
(Total Views: 413)
Posted On: 04/12/2021 1:04:35 PM
Post# of 36564
Posted By: Zolis_onkel
Re: balleroni #28329
Yes, I fully agree with your statements, too.

On the positive side of things, it is surely good to read, that ...

* they have made progress on the IND submission to the FDA, which includes that they have completed their "homework" (lab testing results, GMP, etc.)
* they emphazise on the fact that there will still be a market for the "Complete Vaccine" even if it won't be available before Q1 2022.
* they pointed out several times that the "Complete Vaccine" can be transported at room temperature in form of a simple powder to even the most remote locations of this planet.
* they believe that their ii-key Covid vaccine is likely going to be much versatily effective against multiple strains of the Corona virus, and I especially liked their line of thought comparing the effectiveness of their vaccine even against the SARS-I virus. This should give a lot of people a good idea how "complete" the NGIO Corona vaccine really is.
* the suggested long term immunity is based on lab results as well as their previous experience with the breast cancer vaccine, which proves the immunity even after 10 years.

Still, my issues with the PR, as stated before remain!













(2)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site